D-0769-2026 Class I Ongoing

Recalled by Buy-Herbal — Flushing, NY

FDA drug recall D-0769-2026 was initiated by Buy-Herbal on Mar 21, 2026 and is designated Class I. Reason for recall: Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine. The recall status is ongoing. Affected quantity: 71 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 19, 2026
Initiation Date
Mar 21, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
71 bottles

Product description

Kian Pee Wan Capsules, 30-count bottles

Reason for recall

Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

Distribution pattern

Product was sold to individual consumers via ebay third party seller.

Code information

All lots within expiry.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0769-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0769-2026. Report a data issue: hello@regdatalab.com.